DANIPHARM A/S
CVR 12335040 · Public limited company (A/S) · Active · Low risk
DANIPHARM A/S is a Public limited company (A/S), founded on , based in Kastrup. The company is registered in the industry fremstilling af farmaceutiske råvarer. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (30 Jun 2025) shows equity of DKK 60.3m and a net result of DKK 13.7m. CEO: Peter Rørvig.
Bankruptcy risk for DANIPHARM A/S
0.0 × the average (1.41%) · higher risk than 6% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 12335040
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (38 years)
- Address
- Englandsvej 350
2770 Kastrup - Municipality
- Tårnby
- Industry
- Fremstilling af farmaceutiske råvarer (211000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 500k
- Employees
- 24 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 30 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 53.3% |
| Current ratio | 219% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 6 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 5 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 37.6m | DKK 27.1m |
| Net profit | DKK 13.7m | DKK 5.1m |
| Equity | DKK 60.3m | DKK 46.6m |
| Total assets | DKK 113.0m | DKK 95.6m |
| Cash | DKK 231 | – |
| Short-term debt | DKK 47.2m | – |
| Avg. employees | 28 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2024 – 30 Jun 2025 | 163 | ||
| 1 Jul 2023 – 30 Jun 2024 | 166 | ||
| 1 Jul 2022 – 30 Jun 2023 | 174 | ||
| 1 Jul 2021 – 30 Jun 2022 | 158 | ||
| 1 Jul 2020 – 30 Jun 2021 | 160 | ||
| 1 Jul 2019 – 30 Jun 2020 | 130 | ||
| 1 Jul 2018 – 30 Jun 2019 | 155 | ||
| 1 Jul 2017 – 30 Jun 2018 | 171 | ||
| 1 Jul 2016 – 30 Jun 2017 | 174 | ||
| 1 Jul 2015 – 30 Jun 2016 | 161 | ||
| 1 Jul 2014 – 30 Jun 2015 | 164 | ||
| 1 Jul 2013 – 30 Jun 2014 | 171 | ||
| 1 Jul 2012 – 30 Jun 2013 | 165 | ||
| 1 Jul 2011 – 30 Jun 2012 | 157 | ||
| 1 Jul 2010 – 30 Jun 2011 | 152 | ||
| 1 Jul 2009 – 30 Jun 2010 | 146 | ||
| 1 Jul 2008 – 30 Jun 2009 | 120 | ||
| 1 Jul 2007 – 30 Jun 2008 | 146 | ||
| 1 Jul 2006 – 30 Jun 2007 | 155 | ||
| 1 Jul 2005 – 30 Jun 2006 | 142 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Rørvig | Current | |
| CEO | Per Emil Hasselbalch Stakemann | ||
| CEO | Niels Otto Thiesen | ||
| CEO | Erik Vilhelm Balslev | ||
| CEO | Peter Rørvig | ||
| Board | Helle Rørvig | Current | |
| Board | Niels Ulrik Heine | Current | |
| Board | Peter Rørvig | Current | |
| Board | Erik Vilhelm Balslev | ||
| Board | Niels Otto Thiesen | ||
| Board | Svend Blankholm | ||
| Owner (100%) | H&P Rørvig Holding A/S | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | Erik Tronborg Andersen | ||
| Auditor | Svend Blankholm | ||
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Founder | VX 10.312 ApS | Current |
The CEOs' other companies
Peter Rørvig – 9 other companies
- A/S ORTHANA KEMISK FABRIK Active
- BIOFAC A/S Active
- BIOFAC HOLDING A/S Fusioneret
- H&P Rørvig Holding A/S Active
- N. THIESEN HOLDING A/S Active
- PHARMADAN A/S Active
- PHARMADAN ApS Fusioneret
- R & S PHARMADAN ApS Fusioneret
- ZPD A/S Active
Per Emil Hasselbalch Stakemann – 45 other companies, of which 45 bankrupt
- "HEDEVANG MØBLER A/S" Bankrupt 27 Nov 1990
- "J.A.M. TRANSPORTBÅND A/S" Bankrupt 18 Aug 1993
- "NELLE'S RENGØRING A/S" Bankrupt 16 Jul 1990
- 'HG 405 PAVIA AF HIRTSHALS ApS' Bankrupt 4 Jul 2007
- 'ZOO-TEX ApS' Bankrupt 25 Nov 2016
- 02 HOLDING A/S Bankrupt 16 Oct 2008
- 09.28 ANNO 2007 ApS Bankrupt 13 Feb 2009
- 1/7 1987 A/S Bankrupt 21 Aug 2003
- 100 GB ApS Bankrupt 5 May 1994
- 11 DESIGN A/S Bankrupt 28 Apr 2015
- 1356 INVEST ApS Bankrupt 8 Apr 2011
- 15/11 1990 A/S Bankrupt 11 Oct 1994
- 15689382 ApS Bankrupt 26 Jun 2017
- 19.09.2021 ApS Bankrupt 8 Dec 2023
- 23/5 914 ApS Bankrupt 25 Jun 1991
- 3 X 65 SERVICE ApS Bankrupt 3 Mar 1997
- 3 X P A/S Bankrupt 10 Sep 1990
- 31.12.2007 X A/S Bankrupt 28 Oct 2008
- 3B DEVELOPMENT GROUP ApS Bankrupt 2 Nov 2006
- 4 FONTANE ApS Bankrupt 2 Oct 2002
- 4A MANAGEMENT ApS Bankrupt 7 May 1992
- 7 9 13 FORSIKRINGSERVICE ApS Bankrupt 20 Mar 2024
- A - INFORMATIK A/S Bankrupt 9 Oct 2013
- A J J FINANS NR. 1 ApS Bankrupt 23 Feb 1995
- A'SHARQ TV ApS Bankrupt 26 Nov 1992
- A-T SPECIALENTREPRICE ApS Bankrupt 3 Aug 2001
- A. K. OLIE ApS Bankrupt 18 Nov 2008
- A. UNO ApS Bankrupt 19 Jan 1996
- A.B. BYG ApS Bankrupt 4 Dec 1996
- A.H. GRAFIK ApS Bankrupt 23 Jan 1990
Niels Otto Thiesen – 17 other companies, of which 3 bankrupt
- Byrd ApS Bankrupt 17 Nov 2023
- Cuttles ApS Bankrupt 21 Jan 2025
- deepdivr.io ApS Bankrupt 30 Aug 2023
- A/S ORTHANA KEMISK FABRIK Active
- BIOFAC A/S Active
- BIOFAC HOLDING A/S Fusioneret
- Byrd Holding ApS Opløst
- EJENDOMSSELSKABET SKÆLSKØR ApS Opløst
- Ejendomsselskabet Glentevej Herning ApS Opløst
- Ejendomsselskabet Klostermuren ApS Active
- H&P Rørvig Holding A/S Active
- Inboxers ApS Opløst
- N. THIESEN HOLDING A/S Active
- PHARMADAN A/S Active
- PHARMADAN ApS Fusioneret
- R & S PHARMADAN ApS Fusioneret
- TRUSTPILOT A/S Active
Erik Vilhelm Balslev – 3 other companies
- A/S ORTHANA KEMISK FABRIK Active
- BIOFAC A/S Active
- PHARMADAN ApS Fusioneret
Address history (1 moves)
| Englandsvej 350, 2770 Kastrup | |
| Englandsvej 350, 2770 Kastrup |
Former names
| DANIPHARM A/S | – now |
| ApS KBUS 8 NR.3500 | – |
Employees per year
Other companies at the same address
- A/S ORTHANA KEMISK FABRIK Active
- BIOFAC A/S Active
- BIOFAC HOLDING A/S Fusioneret
- PHARMADAN A/S Active
- PHARMADAN ApS Fusioneret
Similar companies in Tårnby
- BIOFAC A/S Kastrup
- A/S ORTHANA KEMISK FABRIK Kastrup
Questions and answers about DANIPHARM A/S
Has DANIPHARM A/S gone bankrupt?
No, DANIPHARM A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of DANIPHARM A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of DANIPHARM A/S?
Peter Rørvig is the CEO of DANIPHARM A/S.
Who is the auditor of DANIPHARM A/S?
DANIPHARM A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was DANIPHARM A/S founded?
DANIPHARM A/S was founded on 1 August 1988.
What is the equity of DANIPHARM A/S?
Equity was DKK 60.3m according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.